Buscar
Mostrando ítems 61-70 de 284
Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge
(Public Library of Science, 2014-08)
There is a critical need for new influenza vaccines able to protect against constantly emerging divergent virus strains. This will be sustained by the induction of vigorous cellular responses and humoral immunity capable ...
Eficacia de haloxifop-r-metil con distintos coadyuvantes
(Facultad de Ciencias Agrarias, Universidad Nacional del Litoral, 2018)
En Argentina se han confirmado trece biotipos de malezas resistentes a glifosato, ocho son gramíneas y para su control se recomiendan herbicidas como haloxifop-R-metil con el agregado de aceite mineral. En el mercado se ...
The vaccine candidate BLSOmp31 protects mice against Brucella canis infection
(Elsevier, 2013-12)
Canine brucellosis represents a major reproductive problem worldwide and it is considered a zoonotic disease. New approaches are therefore urgently needed to develop an effective and safe immunization strategy against ...
The Trypanosoma cruzi TcTASV-C protein subfamily administrated with U-Omp19 promotes a protective response against a lethal challenge in mice
(Elsevier, 2020-11)
The development of a Chagaś disease vaccine has yet the need for the identification of novel combinations of antigens and adjuvants. Here, the performance of TcTASV-C proteins that are virulence factors of trypomastigotes ...
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review
(Elsevier, 2021-09)
Background: Rapid assessment of COVID-19 vaccine safety during pregnancy is urgently needed. Methods: We conducted a rapid systematic review, to evaluate the safety of COVID-19 vaccines selected by the COVID-19 Vaccines ...
U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge
(Elsevier, 2020-07)
Acute diarrhea disease caused by bacterial infections is a major global health problem. Enterotoxigenic Escherichia coli (ETEC) is one of the top causes of diarrhea-associated morbidity and mortality in young children and ...
Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide
(BioMed Central, 2019-03)
Background: The 90-kDa heat-shock protein (Hsp90) from Nicotiana benthamiana (NbHsp90.3) is a promising adjuvant, especially for those vaccines that require a T cell-mediated immune response. Toxoplasma gondii SAG1 is ...
ИСПОЛЬЗОВАНИЕ ЛАКТОБАЦИЛЛ В КАЧЕСТВЕ АДЪЮВАНТОВ ПРИ ИНТРАНАЗАЛЬНОЙ ИММУНИЗАЦИИ ХИМЕРНОЙ ПНЕВМОКОККОВОЙ ВАКЦИНОЙEvaluation of probiotic lactobacillus as adjuvants for nasal immunization with chimeric pneumococcal vaccine
(SPb RAACI, 2016-09)
Vaccine protection against photogenic gram-positive bacteria including different species ofstreptococci is an important problem of contemporary molecular biology. Streptococcal infections are mostcommon bacterial infections ...
Adjuvant effects of Lactobacillus casei added to a renutrition diet in a malnourished mouse model
(Sociedad Latinoamericana de Microscopía Electrónica, 2002-04)
Nutritional deficiencies are associated with impaired immune response, affecting the body’s defence mechanisms. It is also known that Lactic Acid Bacteria (LAB) and fermented products such us yogurt have immunopotentiator ...
Evaluation of vitamin-producing and immunomodulatory lactic acid bacteria as a potential co-adjuvant for cancer therapy in a mouse model
(Wiley Blackwell Publishing, Inc, 2021-06)
Aims: To evaluate a mixture of selected lactic acid bacteria (LAB) (a riboflavin-producer, a folate-producer and an immunomodulatory strain) as co-adjuvant for 5-fluorouracil (5-FU) chemotherapy in cell culture and using ...